ArticleCancers2022

Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene.

Olha Kholod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.